on-01910 and Leukemia--Erythroblastic--Acute

on-01910 has been researched along with Leukemia--Erythroblastic--Acute* in 1 studies

Other Studies

1 other study(ies) available for on-01910 and Leukemia--Erythroblastic--Acute

Article	Year
[Anti-Tumor Effect of Rigosertib on HEL and K562 Cells and Its Related Mechanism]. Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:5 To investigate the effects of rigosertib on the apoptosis, proliferation and cell cycle of HEL and K562 cells.. The HEL and K562 cells were treated with different concentration of rigosertib at different time points, the cell apoptosis, proliferation and cycle were determined by using flow cytometry with Annexin V/PI double staining, WST-1 method and 7-AAD assay, respectively. Intracellular signaling proteins were detected by flow cytometry (FCM). Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Glycine; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Sulfones	2017

Article

Year

[Anti-Tumor Effect of Rigosertib on HEL and K562 Cells and Its Related Mechanism].

Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:5

To investigate the effects of rigosertib on the apoptosis, proliferation and cell cycle of HEL and K562 cells.. The HEL and K562 cells were treated with different concentration of rigosertib at different time points, the cell apoptosis, proliferation and cycle were determined by using flow cytometry with Annexin V/PI double staining, WST-1 method and 7-AAD assay, respectively. Intracellular signaling proteins were detected by flow cytometry (FCM).

Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Glycine; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Sulfones

2017